Ovoca Bio is a clinical-stage biopharmaceutical company with a focus on women’s health. The Company is currently developing a novel treatment for women with hypoactive sexual desire disorder (HSDD), a condition characterized by a distressing lack or loss of sexual desire. The Society for Women’s Health Research estimates that about one in ten premenopausal women suffer from HSDD, making it one of the most common female sexual problems.
Founded and incorporated in Ireland, Ovoca Bio currently operates in Ireland, the UK, and Russia, and is listed on AIM and Euronext Growth in London and Dublin.
Company Details
- Employees
- 2
- Address
- Dublin, Ie
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://ovocabio.com/
- Keywords
- Pharmaceutical Manufacturing.
- HQ
- Dublin
Ovoca Bio Plc Questions
Ovoca Bio Plc's website is https://ovocabio.com/
Ovoca Bio Plc's LinkedIn profile is https://ie.linkedin.com/company/ovoca-bio-plc
Ovoca Bio Plc has
2 employees.
View email and phone details for 2
employees at Ovoca Bio Plc.
Ovoca Bio Plc's industry is
Biotechnology Research
Ovoca Bio Plc's top competitors are
Sterling Pharma Solutions,
Optum Pharma,
Hitech Health,
Aerogen Pharma,
Aenova Group,
Sk Pharmteco,
Sharp Services,
C2 Pharma,
Camida,
Venn Life Sciences - Part Of Hvivo Plc.
Ovoca Bio Plc's categories are Biotechnology Research
